Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets

Published:2002-03-12 Issue:2 Volume:99 Page:157-166
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vihinen Pia,Kähäri Veli-Matti

Funder

Academy of Finland

Turku University Central Hospital

Sigrid Jusélius Foundation

Cancer Foundation of Finland

Cancer Foundation of South-Western Finland

Finnish Life and Pension Insurance Companies

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference165 articles.

1. Matrix metalloproteinases;Nagase;J Biol Chem,1999

2. Matrix metalloproteinase degradation of extracellular matrix: biological consequences;Shapiro;Curr Opin Cell Biol,1998

3. Regulation of matrix metalloproteinase expression in tumour invasion;Westermarck;FASEB J,1999

4. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas;Freije;J Biol Chem,1994

5. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck;Johansson;Am J Pathol,1997

Cited by 543 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNA and Drug resistance in cholangiocarcinoma;Non-coding RNA Research;2024-03

2. Deep‐learning based classification of a tumor marker for prognosis on Hodgkin's disease;European Journal of Haematology;2023-08-07

3. Instrumental and transcriptome analysis reveals the chemotherapeutic effects of doxorubicin-loaded black phosphate nanosheets on abiraterone-resistant prostate cancer;Bioorganic Chemistry;2023-08

4. Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites;Human Molecular Genetics;2023-05-10

5. Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential;Pharmaceuticals;2023-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3